Back to Jane Street Group, LLC Jane Street Group, LLC

ACRSACRS

Showing 7 of 24 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in Aclaris Therapeutics, Inc.

No. Jane Street Group exited its ACRS (Aclaris Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 27,216 shares worth $81,920. Jane Street Group first reported ACRS in Q2 2019 and held it in 19 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$95,136

Total Shares Change

-82,727

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$3.75
0
2025-Q4
Decreased
27,216
-62.8%
$81,9200.0%$3.01
0
2025-Q3
New
73,113
—
$138,9150.0%$1.90
34
2025-Q2
Exited
0
-100.0%
$00.0%$1.42
0
2025-Q1
Decreased
390,282
-28.5%
$597,1310.0%$1.53
0
2024-Q4
Increased
545,564
+559.5%
$1.4M0.0%$2.48
41
2024-Q3
Decreased
82,727
-75.3%
$95,1360.0%$1.15
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used